Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Medical Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice
A novel target for next-generation obesity medications is nicotinamide N-methyltransferase (NNMT) 7,8,9,10,11 , an enzyme central to cellular metabolism and energy homeostasis 12
Kholerdi AM, Moradian F, Mehralitabar H
It accelerates aging
Minich and Brown, 2019
It is most often chosen by executives navigating high-stress careers and irregular meal timing, women dealing with post-pregnancy or perimenopausal central weight gain, men struggling with stubborn visceral fat that does not respond to clean eating, athletes wanting to improve body composition without compromising muscle, and patients seeking a gentler alternative to GLP-1 medications such as semaglutide
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
